Sigurd Hermansson
Papers
1
Total Citations
46
H-Index
1
About
Sigurd Hermansson is a leading figure in analytical toxicology, with a primary research focus on the development and application of high-throughput mass spectrometry methods for forensic and clinical drug screening. His most significant contribution lies in pioneering ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) techniques for the rapid, sensitive, and quantitative detection of drugs of abuse in biological matrices. His landmark 2013 paper, "Screening and quantitative determination of drugs of abuse in diluted urine by UPLC–MS/MS," has garnered 46 citations, establishing a foundational protocol that simplifies sample preparation while maintaining rigorous analytical accuracy. This work has directly influenced modern toxicology laboratories by enabling faster, more reliable multi-analyte screening, reducing both cost and turnaround time. Beyond this core achievement, Hermansson’s research has advanced the understanding of drug metabolism and the stability of analytes in urine, contributing to improved forensic evidence interpretation. His methodological innovations have been widely adopted in clinical and forensic settings, underscoring his impact on public health and safety. For students and researchers, Hermansson exemplifies how precise analytical chemistry can transform routine drug testing into a powerful tool for both clinical diagnostics and legal investigations.
Research Focus
Key Achievements
Top Papers
- 1